ACIM
RMD icon

Azimuth Capital Investment Management’s ResMed RMD Stock Holding History

Azimuth Capital Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2M Sell
54,275
-1,250
-2% -$312K 0.46% 74
2025
Q4 		$13.4M Sell
55,525
-150
-0.3% -$38.4K 0.48% 63
2025
Q3 		$15.2M Sell
55,675
-2,450
-4% -$669K 0.55% 55
2025
Q2 		$15M Sell
58,125
-1,680
-3% -$401K 0.56% 52
2025
Q1 		$13.4M Sell
59,805
-1,355
-2% -$316K 0.53% 52
2024
Q4 		$14M Sell
61,160
-1,175
-2% -$283K 0.54% 54
2024
Q3 		$15.2M Sell
62,335
-2,425
-4% -$542K 0.59% 49
2024
Q2 		$12.4M Sell
64,760
-1,710
-3% -$347K 0.5% 57
2024
Q1 		$13.2M Sell
66,470
-310
-0.5% -$56.8K 0.54% 58
2023
Q4 		$11.5M Buy
66,780
+250
+0.4% +$38.4K 0.52% 64
2023
Q3 		$9.84M Buy
66,530
+1,075
+2% +$194K 0.48% 65
2023
Q2 		$14.3M Sell
65,455
-365
-0.6% -$81.3K 0.68% 47
2023
Q1 		$14.4M Sell
65,820
-290
-0.4% -$62.9K 0.71% 44
2022
Q4 		$13.8M Buy
66,110
+225
+0.3% +$49.4K 0.7% 44
2022
Q3 		$14.4M Sell
65,885
-454
-0.7% -$103K 0.79% 35
2022
Q2 		$13.9M Buy
+66,339
New +$14.1M 0.7% 43

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Azimuth Capital Investment Management's RMD Position: Q1 2026 in Review

Azimuth Capital Investment Management reduced its ResMed (RMD) stake by 2.3% in Q1 2026, selling an estimated $312K and leaving 54,275 shares worth $12.2M. The position accounts for 0.46% of the portfolio, ranked #74.

Azimuth Capital Investment Management first reported a position in RMD in Q2 2022 and has held it in 16 quarters since. The position peaked at $15.2M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Azimuth Capital Investment Management held 54,275 shares of ResMed worth $12.2M as of Q1 2026.
  • Azimuth Capital Investment Management sold 1,250 ResMed shares in Q1 2026, an estimated $312K.
  • ResMed made up 0.46% of Azimuth Capital Investment Management's portfolio in Q1 2026, its #74 holding.
  • Azimuth Capital Investment Management first reported a position in ResMed in Q2 2022 and has held it in 16 quarters since.
  • Azimuth Capital Investment Management's ResMed position peaked at $15.2M in Q3 2025.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Azimuth Capital Investment Management's 13F filing for Q1 2026, filed 12 May 2026.